(Q53462473)

English

Assessment of the therapeutic potential of cytokines, cytotoxic drugs and effector cell populations for the treatment of multiple myeloma using the 5T33 murine myeloma model.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

Assessment of the therapeutic potential of cytokines, cytotoxic drugs and effector cell populations for the treatment of multiple myeloma using the 5T33 murine myeloma model. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

0 references

author name string

Manning LS

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

Chamberlain NL

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

Leahy MF

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

Cordingley FT

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

publication date

1 August 1995

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

Immunology & Cell Biology

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

73

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

326-332

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

21 January 2018

Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

21 January 2018

A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

21 January 2018

Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

21 January 2018

Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

21 January 2018

He's not going to talk about in vitro predictive assays again, is he?

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

21 January 2018

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines involved in the progression of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of interferon on antibody production and viability of malignant cells from patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon- γ inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/ICB.1995.50

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/7493769

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53462473&oldid=1507208846"